Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endosomal lipid bilayer is a dynamic, semi-permeable membrane that defines the boundaries of endosomes, playing a critical role in the sorting and trafficking of internalized extracellular material and surface receptors. It is composed of a complex mixture of phospholipids, cholesterol, and phosphoinositides that evolve in composition as the endosome matures from early to late stages (Nature Nanotechnology, 2021). This structure serves as a primary barrier for the intracellular delivery of macromolecular therapeutics, such as mRNA and siRNA, which must escape the endosome to reach the cytosol to be functional (Journal of Controlled Release, 2014). In many viral infections, including those caused by influenza and coronaviruses, the endosomal lipid bilayer is the site where viral envelopes fuse with host membranes, a process often triggered by the acidic environment of the endosomal lumen (Cell, 2014). Drugs targeting this structure typically aim to either facilitate endosomal escape for gene therapy or inhibit viral fusion to prevent infection (PubMed, 16115318). Additionally, alterations in the lipid composition or integrity of this bilayer are implicated in lysosomal storage disorders and neurodegenerative diseases like Alzheimer's (NIH, 2020). Understanding the biophysical properties of the endosomal lipid bilayer is essential for optimizing drug delivery systems and developing novel antiviral strategies.
Facilitation of endosomal escape via pH-triggered membrane destabilization or fusion; inhibition of viral-endosomal membrane fusion; modulation of endosomal pH to disrupt trafficking.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal lipid bilayer.